FDA warns Canadian firm for hostile behavior during inspection, two Indian facilities for GMP issues
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionChemistry, Manufacturing and Controls (CMC)ComplianceGenericsGMPManufacturingPharmaceuticalsQuality Assurance and ControlSupply Chain ManagementUnited StatesWarning letters